|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01889 SANAI HEALTH GP
Nominal 
0.190 -0.003 (-1.554%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 43,923 | -6.986% | 85,900 | 85,217 | 122,098 | 175,923 |
| Cost of Sales | (30,930) | -23.460% | (71,566) | (68,353) | (86,913) | (84,248) |
| Gross Profit | 12,993 | 90.737% | 14,334 | 16,864 | 35,185 | 91,675 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (1,331) | -- | 2,517 | 341 | |
| Profit / (Loss) on Disposal | -- | -- | (774) | (124) | -- | (2,484) | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (633) | (456) | 0 | 0 | |
| Profit / (Loss) before Taxation | (7,818) | -39.456% | (26,997) | (12,939) | 22,364 | 55,771 | |
| Taxation | (367) | -45.306% | 455 | (968) | (8,997) | (20,574) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | 17,308 | -- | -- | |
| Non-controlling Interests | (326) | -- | 4,502 | 1,491 | 5,266 | (5,980) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (8,511) | -23.089% | (22,040) | 4,892 | 18,633 | 29,217 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,631 | 10.952% | 2,660 | 1,630 | 1,607 | 1,713 |
| Depreciation & Amortisation | 1,239 | 13.879% | 3,942 | 2,787 | 4,062 | 3,524 |
| Directors' Emoluments | -- | -- | 2,775 | 2,324 | 1,881 | 5,572 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Qualified | Qualified | Qualified | Qualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -5.570 | -23.066% | -14.410 | 3.370 | 14.520 | 23.750 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.348) | 0.081 | 2.499 | (0.458) |
| NBV per share ($) | 1.110 | -- | 1.951 | 2.106 | 2.059 | 1.921 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -8,511 |
| %Change | -23.089% |
| EPS / (LPS) | RMB -0.056 |
| NBV Per Share (¥) | RMB 1.110 |